TOMI Environmental Solutions, Inc. (TOMZ)

Over the past six months, TOMI's stock has been influenced by several events. The Q1 2026 earnings report showed a revenue increase and positive operating cash flow, leading to a stock surge. TOMI signed a letter of intent to merge with Carbonium Core, Inc., aiming to diversify its business. The company has been strategically expanding into new markets like robotaxi disinfection and defense drones. Regulatory approvals in Europe have supported further expansion. The Q4 2025 earnings report showed a revenue decrease and wider losses. TOMZ shares have increased year-to-date but experienced a decline over the past six months, with some volatility.

While specific seasonal patterns are not publicly detailed, recent company reports suggest consistent and growing demand for TOMI's products and services. The company reported a steady backlog expansion, indicating ongoing demand. TOMI has secured annual purchase orders for recurring decontamination services and has multi-year service contracts in place. The company's strategic diversification aims to broaden its market and potentially stabilize demand throughout the year.

TOMI Environmental Solutions, Inc. specializes in decontamination and infection prevention, operating within the Industrial Goods sector. The company provides environmental solutions for indoor surface disinfection through its Binary Ionization Technology platform, producing ionized Hydrogen Peroxide fog under the SteraMist brand. TOMI offers a range of products and services, including portable and transportable disinfection systems, hospital disinfection carts, applicators, decontamination chambers, and corporate service decontamination. These are utilized across various environments, including hospitals, labs, pharmaceutical facilities, commercial buildings, schools, restaurants, and more.

TOMI Environmental Solutions, Inc. operates in the United States and internationally. The company has expanded its international presence with strategic wins and regulatory approvals in regions such as Mexico, Canada, the UK, the Netherlands, Germany, Belgium, Denmark, and Hungary.

In the past year, TOMI Environmental Solutions has reinforced its brand reputation through the efficacy of its SteraMist iHP disinfection technology. SteraMist iHP plays a critical role in addressing public health risks from rodent-borne pathogens. The company secured new client partnerships within the compounding pharmacy sector due to tightening regulatory standards. TOMI's technology was adopted by a major Mexican dairy facility due to rigorous pathogen testing. The company maintains multi-year service contracts with entities such as MD Anderson Cancer Center and Pfizer.

TOMI Environmental Solutions, Inc. has a diverse ownership structure, with institutional shareholders holding approximately 4.82% of the stock, insiders owning about 15.63%, and retail investors accounting for 79.54%. Major institutional owners include Vanguard Group Inc., Geode Capital Management, Llc., and State Street Corp. Dr. Halden Stuart Shane is the largest individual shareholder, owning 12.36% of the company.